EZZ Life Science Holdings Ltd
ASX:EZZ
Intrinsic Value
EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. [ Read More ]
The intrinsic value of one EZZ stock under the Base Case scenario is 1.75 AUD. Compared to the current market price of 0.94 AUD, EZZ Life Science Holdings Ltd is Undervalued by 46%.
Valuation Backtest
EZZ Life Science Holdings Ltd
Run backtest to discover the historical profit from buying and selling EZZ stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
EZZ Life Science Holdings Ltd
| Current Assets | 19.6m |
| Cash & Short-Term Investments | 12.6m |
| Receivables | 3.3m |
| Other Current Assets | 3.7m |
| Non-Current Assets | 705.6k |
| PP&E | 633.5k |
| Intangibles | 18.9k |
| Other Non-Current Assets | 53.3k |
| Current Liabilities | 5m |
| Accounts Payable | 4.4m |
| Accrued Liabilities | 75.5k |
| Other Current Liabilities | 522.9k |
Earnings Waterfall
EZZ Life Science Holdings Ltd
|
Revenue
|
43.7m
AUD
|
|
Cost of Revenue
|
-11m
AUD
|
|
Gross Profit
|
32.7m
AUD
|
|
Operating Expenses
|
-26.2m
AUD
|
|
Operating Income
|
6.5m
AUD
|
|
Other Expenses
|
-3m
AUD
|
|
Net Income
|
3.5m
AUD
|
Free Cash Flow Analysis
EZZ Life Science Holdings Ltd
EZZ Profitability Score
Profitability Due Diligence
EZZ Life Science Holdings Ltd's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
Score
EZZ Life Science Holdings Ltd's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
EZZ Solvency Score
Solvency Due Diligence
EZZ Life Science Holdings Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
EZZ Life Science Holdings Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EZZ Price Targets Summary
EZZ Life Science Holdings Ltd
According to Wall Street analysts, the average 1-year price target for EZZ is 1.49 AUD with a low forecast of 1.47 AUD and a high forecast of 1.53 AUD.
Shareholder Return
EZZ Price
EZZ Life Science Holdings Ltd
| Average Annual Return | -38.69% |
| Standard Deviation of Annual Returns | 23.34% |
| Max Drawdown | -76% |
| Market Capitalization | 40.1m AUD |
| Shares Outstanding | 44 413 200 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. The company develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.
Contact
IPO
Employees
Officers
The intrinsic value of one EZZ stock under the Base Case scenario is 1.75 AUD.
Compared to the current market price of 0.94 AUD, EZZ Life Science Holdings Ltd is Undervalued by 46%.
You don't have any saved screeners yet
